FDA Inspection
HansBiomed USA, Inc.HansBiomed USA, Inc. – FDA Inspection, Apr 2, 2013
Record Details
This FDA Inspection record concerns HansBiomed USA, Inc., with an inspection on April 2, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- HansBiomed USA, Inc.
- Inspection Date
- April 2, 2013
- Product Type
- Biologics
View Company Profile
ID · 3c1de524-74b0-415a-b6a8-143c3dfe1bd0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 825938
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.265(d)Shipping conditions appropriate
- 21 CFR 1271.290(b)Establishing a system
- 21 CFR 1271.320(a)Procedures re complaints
Full citation text and observation details available on the Dashboard.
Other FDA inspections of HansBiomed USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2022 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 27, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 3, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 14, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for HansBiomed USA, Inc.
- FDA Inspection 1187489 - 2022-11-08
- FDA Inspection 1181084 - 2022-09-27
- FDA Inspection 1107099 - 2019-09-03
- FDA Inspection 941986 - 2015-09-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.